AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by AC Immune SA, a foreign private issuer based in Lausanne, Switzerland, for the month of June 2019. The filing, dated June 4, 2019, serves primarily to distribute materials related to the company's 2019 Annual General Meeting of Ordinary Shareholders.
Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the current period. This document acts as a conduit for shareholder meeting materials rather than a financial results report. Historical financial statements for the years ended December 31, 2018, 2017, and 2016 are incorporated by reference from the company's Form 20-F filed on March 21, 2019.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document focuses on corporate governance activities, specifically the convening of the Annual General Meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk disclosures. It includes an invitation to the Ordinary Shareholders' Meeting, a proxy card, and instructions on how to become a holder of record. The 2018 Statutory Annual Report and Compensation Report are also referenced but not detailed within this text.
Key Facts for Investor Verification
- The filing is procedural, distributing materials for the 2019 Annual General Meeting rather than reporting new financial results.
- Financial data for 2018 and prior years must be verified in the Form 20-F filed on March 21, 2019, as referenced in Exhibit 99.4.
- Shareholders should review the attached proxy materials (Exhibits 99.1 and 99.2) for voting instructions and agenda items.
- The company's principal executive office is located at EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.